SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Gilead Sciences
Gilead Sciences
Health
U.S. approves twice-a-year shot to prevent HIV but cuts to public health and foreign aid cloud its prospects
By
Lauran Neergaard
and
The Associated Press
June 19, 2025
Health
In patient with long-term COVID-19, coronavirus mutated to resist antiviral Remdesivir
By
Jason Gale
and
Bloomberg
November 11, 2021
Conferences
Can the pandemic-induced collaboration among health care companies have a real impact on inequality?
By
Sheryl Estrada
April 29, 2021
Conferences
Gilead’s remdesivir is now used to treat half of hospitalized COVID patients
By
Sy Mukherjee
April 28, 2021
Health
Gilead shares jump on FDA approval of remdesivir
By
Robert Langreth
and
Bloomberg
October 23, 2020
Health
Gilead says remdesivir slashes coronavirus deaths. But it’s complicated
By
Sy Mukherjee
July 10, 2020
Health
Gilead to charge thousands for coronavirus treatment drug that critics say should cost $1
By
Robert Langreth
and
Bloomberg
June 29, 2020
Newsletters
The April stocks rally defied the odds. Here’s what’s driving markets
By
Bernhard Warner
April 30, 2020
Magazine
Big Pharma has the chance to come to the world’s rescue
By
Sy Mukherjee
April 20, 2020
Health
Gilead stock surges on report of coronavirus drug patients ‘seeing rapid recoveries’
By
Drew Armstrong
and
Bloomberg
April 16, 2020
Newsletters
Gilead made a remarkable request of the FDA in regard to its coronavirus drug
By
Sy Mukherjee
March 25, 2020
International
HIV pill fails while flu medication helps in early coronavirus drug trials
By
Jason Gale
and
Bloomberg
March 19, 2020
Most Popular
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
By
Jason Ma
Success
Be careful boomers, your Gen Z coworker may be recording you — 9-to-5s aren’t just about climbing the ladder, they’re...
By
Jessica Coacci
Success
This Stanford computer science professor went to written exams 2 years ago because of AI. He says his students insisted...
By
Nick Lichtenberg